Microbot Medical Inc (NASDAQ:MBOT) saw a large drop in short interest in July. As of July 15th, there was short interest totalling 24,500 shares, a drop of 10.6% from the June 15th total of 27,400 shares. Based on an average trading volume of 45,800 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.8% of the shares of the company are short sold.

NASDAQ:MBOT traded up $0.12 during midday trading on Tuesday, reaching $6.76. 49,300 shares of the company traded hands, compared to its average volume of 877,327. Microbot Medical has a twelve month low of $1.38 and a twelve month high of $19.40. The stock has a market capitalization of $28.62 million, a price-to-earnings ratio of -2.80 and a beta of 4.90. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 0.03. The firm has a fifty day moving average of $5.34.

Microbot Medical (NASDAQ:MBOT) last released its quarterly earnings data on Wednesday, May 15th. The biotechnology company reported ($0.48) earnings per share (EPS) for the quarter. On average, sell-side analysts predict that Microbot Medical will post -1.46 earnings per share for the current year.

An institutional investor recently bought a new position in Microbot Medical stock. Geode Capital Management LLC bought a new stake in shares of Microbot Medical Inc (NASDAQ:MBOT) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 22,151 shares of the biotechnology company’s stock, valued at approximately $38,000. Geode Capital Management LLC owned approximately 0.51% of Microbot Medical at the end of the most recent reporting period. 14.00% of the stock is currently owned by institutional investors.

Separately, HC Wainwright lifted their target price on Cara Therapeutics from $28.00 to $31.00 and gave the stock an “average” rating in a research report on Monday, July 22nd.

Microbot Medical Company Profile

Microbot Medical Inc, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures.

Recommended Story: Conference Calls and Individual Investors

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.